Purdue Pharma L.P. v. United States ex rel. May

135 S. Ct. 2376, 192 L. Ed. 2d 177, 83 U.S.L.W. 3879, 2015 U.S. LEXIS 3659
CourtSupreme Court of the United States
DecidedJune 1, 2015
DocketNo. 13–1162.
StatusPublished

This text of 135 S. Ct. 2376 (Purdue Pharma L.P. v. United States ex rel. May) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Purdue Pharma L.P. v. United States ex rel. May, 135 S. Ct. 2376, 192 L. Ed. 2d 177, 83 U.S.L.W. 3879, 2015 U.S. LEXIS 3659 (U.S. 2015).

Opinion

Motion of The Pharmaceuticals Research and Manufacturers of America, et al. for leave to file a brief as amici curiaegranted. Motion of Washington Legal Foundation for leave to file a brief as amicus curiaegranted. Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
135 S. Ct. 2376, 192 L. Ed. 2d 177, 83 U.S.L.W. 3879, 2015 U.S. LEXIS 3659, Counsel Stack Legal Research, https://law.counselstack.com/opinion/purdue-pharma-lp-v-united-states-ex-rel-may-scotus-2015.